Journal of Pediatric Neurology 2017; 15(02): 073-075
DOI: 10.1055/s-0036-1593885
Case Report
Georg Thieme Verlag KG Stuttgart · New York

Novel Mutation in PLA2G6 Gene in a Patient with Infantile Neuroaxonal Dystrophy

Aravindhan Veerapandiyan
1   Division of Pediatric Neurology, Department of Neurology, Rutgers New Jersey Medical School, Newark, New Jersey, United States
,
Amit Chaudhari
1   Division of Pediatric Neurology, Department of Neurology, Rutgers New Jersey Medical School, Newark, New Jersey, United States
,
Akilandeswari Aravindhan
1   Division of Pediatric Neurology, Department of Neurology, Rutgers New Jersey Medical School, Newark, New Jersey, United States
,
Caroline Hayes-Rosen
1   Division of Pediatric Neurology, Department of Neurology, Rutgers New Jersey Medical School, Newark, New Jersey, United States
› Author Affiliations
Further Information

Publication History

01 September 2016

28 September 2016

Publication Date:
04 November 2016 (online)

Abstract

Infantile neuroaxonal dystrophy (INAD) is an autosomal recessive disorder that causes psychomotor regression. Clinicopathological features include truncal hypotonia followed by spastic quadriparesis, strabismus, nystagmus, cerebellar ataxia, bulbar dysfunction, and cerebellar atrophy. INAD is associated with a variety of mutations in the PLA2G6 gene that encodes the group VI calcium-independent phospholipase A2 protein which is important in cell membrane homeostasis. Defects in this protein cause axonal dystrophy. We report a 2-year-old boy with INAD who was found to have a novel deletion c.1019_1025del7 leading to a frame shift in the PLA2G6 gene. We suggest that this change may be an addition to the array of mutations causing INAD.

 
  • References

  • 1 Aicardi J, Castelein P. Infantile neuroaxonal dystrophy. Brain 1979; 102 (04) 727-748
  • 2 Kurian MA, Morgan NV, MacPherson L , et al. Phenotypic spectrum of neurodegeneration associated with mutations in the PLA2G6 gene (PLAN). Neurology 2008; 70 (18) 1623-1629
  • 3 Salih MA, Mundwiller E, Khan AO , et al. New findings in a global approach to dissect the whole phenotype of PLA2G6 gene mutations. PLoS One 2013; 8 (10) e76831 DOI: 10.1371/journal.pone.0076831.
  • 4 Khateeb S, Flusser H, Ofir R , et al. PLA2G6 mutation underlies infantile neuroaxonal dystrophy. Am J Hum Genet 2006; 79 (05) 942-948
  • 5 Butzer JF, Schochet Jr SS, Bell WE. Infantile neuroaxonal dystrophy. An electron microscopic study of a case clinically resembling neuronal ceroid-lipofuscinosis. Acta Neuropathol 1975; 31 (01) 35-43
  • 6 Itoh K, Negishi H, Obayashi C , et al. Infantile neuroaxonal dystrophy--immunohistochemical and ultrastructural studies on the central and peripheral nervous systems in infantile neuroaxonal dystrophy. Kobe J Med Sci 1993; 39 (04) 133-146
  • 7 Morgan NV, Westaway SK, Morton JE , et al. PLA2G6, encoding a phospholipase A2, is mutated in neurodegenerative disorders with high brain iron. Nat Genet 2006; 38 (07) 752-754
  • 8 Solomons J, Ridgway O, Hardy C , et al. Infantile neuroaxonal dystrophy caused by uniparental disomy. Dev Med Child Neurol 2014; 56 (04) 386-389
  • 9 Gregory A, Kurian MA, Maher ER, Hogarth P, Hayflick SJ. PLA2G6-associated neurodegeneration. In: Pagon RA, Adam MP, Ardinger HH, , et al., eds. GeneReviews . Seattle, WA: Washington University; 1993
  • 10 Nardocci N, Zorzi G, Farina L , et al. Infantile neuroaxonal dystrophy: clinical spectrum and diagnostic criteria. Neurology 1999; 52 (07) 1472-1478
  • 11 Illingworth MA, Meyer E, Chong WK , et al. PLA2G6-associated neurodegeneration (PLAN): further expansion of the clinical, radiological and mutation spectrum associated with infantile and atypical childhood-onset disease. Mol Genet Metab 2014; 112 (02) 183-189
  • 12 Paisan-Ruiz C, Bhatia KP, Li A , et al. Characterization of PLA2G6 as a locus for dystonia-parkinsonism. Ann Neurol 2009; 65 (01) 19-23
  • 13 Shi CH, Tang BS, Wang L , et al. PLA2G6 gene mutation in autosomal recessive early-onset parkinsonism in a Chinese cohort. Neurology 2011; 77 (01) 75-81
  • 14 Levi S, Finazzi D. Neurodegeneration with brain iron accumulation: update on pathogenic mechanisms. Front Pharmacol 2014; 5: 99 DOI: 10.3389/fphar.2014.00099.
  • 15 Engel LA, Jing Z, O'Brien DE, Sun M, Kotzbauer PT. Catalytic function of PLA2G6 is impaired by mutations associated with infantile neuroaxonal dystrophy but not dystonia-parkinsonism. PLoS One 2010; 5 (09) e12897 DOI: 10.1371/journal.pone.0012897.